Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $5 | $12 | $20 | $25 |
| - Cash | $18 | $21 | $23 | $24 |
| + Debt | $25 | $26 | $26 | $26 |
| Enterprise Value | $12 | $16 | $23 | $26 |
| Revenue | $9 | $11 | $9 | $19 |
| % Growth | -18.2% | 22.3% | -51.3% | – |
| Gross Profit | $4 | $2 | $1 | $4 |
| % Margin | 38.8% | 13.8% | 11.7% | 19.1% |
| EBITDA | $2 | -$5 | -$6 | -$10 |
| % Margin | 16.5% | -45.7% | -61.2% | -51.9% |
| Net Income | -$1 | -$7 | -$7 | -$9 |
| % Margin | -9.3% | -59.8% | -75.8% | -46.7% |
| EPS Diluted | -0.035 | -0.26 | -0.23 | -0.29 |
| % Growth | 86.5% | -13% | 20.7% | – |
| Operating Cash Flow | -$3 | -$5 | -$0 | -$4 |
| Capital Expenditures | $0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$3 | -$5 | -$1 | -$5 |